BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

1st Patient in Illinois Discharged Home With the SynCardia Systems, Inc. Total Artificial Heart


9/27/2012 9:46:07 AM

TUCSON, Ariz., Sept. 27, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Advocate Christ Medical Center in Oak Lawn, Illinois, has discharged its first patient to receive the SynCardia temporary Total Artificial Heart. Leroy Haynes, 64, left the hospital using the FreedomĀ® portable driver on Sept. 13, to resume life at home with his wife Pat while he waits for a matching donor heart.

(Photo: http://photos.prnewswire.com/prnh/20120927/LA82087)

"I can't thank you enough," Haynes told his doctors and nurses during a news conference with his wife by his side. "We're just simple people. We've worked all of our lives and it seems saying thank you is not good enough There's not a person that didn't smile, give me encouragement, tell me I'm going home, and now that day has come."

Haynes, a letter carrier who retired from the post office in 2007, had been suffering from cardiomyopathy, a disease that weakens and enlarges the heart muscle. In 2008, he received a HeartMate II left ventricular assist device (LVAD). An LVAD is a continuous-flow, mechanical pump that is implanted adjacent to the heart to help the left ventricle pump blood. However, this April, Haynes was admitted to the hospital after his condition began to rapidly deteriorate.

Over several weeks, he experienced persistent ventricular tachycardia (a fast heart rhythm that starts in the lower part of the heart), which caused continuous shocks from his implantable cardioverter defibrillator (ICD). To save his life, on May 8, doctors removed Haynes' failing heart and LVAD, and implanted their first SynCardia Total Artificial Heart to bridge him to a donor heart transplant.

"Yes our life is going to change," said his wife Pat, who is a home health care nurse. "It's a new way of living, but we're happy we have more time together."

Before heading home, the couple, who recently celebrated their 42nd wedding anniversary in the hospital, was presented with a gift certificate to a local restaurant so they could enjoy a proper celebration.

Weighing 13.5 pounds, the Freedom portable driver is the world's first wearable power supply for the SynCardia Total Artificial Heart. The Freedom driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.

View news coverage of Advocate Christ's first discharge

Watch videos about Advocate Christ's first discharge

Read press release from Advocate Christ

CAUTION The Freedom portable driver is an investigational device, limited by United States law to investigational use.

Like SynCardia on Facebook

Follow SynCardia on Twitter @SynCardia

Connect with SynCardia on LinkedIn

About the SynCardia temporary Total Artificial Heart

SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart read more

SOURCE SynCardia Systems, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES